Chemed Corporation Reports Strong Q1 2025 Growth Amid Rising Costs and Cash Flow Concerns

Chemed Corporation (NYSE: CHE) has recently reported its financial results for the first quarter ended March 31, 2025. Below are the key highlights from the income statement, along with positive and negative aspects of the company's performance.

Positive Aspects:

• Service Revenues and Sales: Increased to $646,943K in Q1 2025 from $589,233K in Q1 2024, a growth of 9.8%.
• Net Income: Rose to $71,757K in Q1 2025 from $65,017K in Q1 2024, marking an increase of 10.3%.
• Earnings Per Share: Diluted EPS increased to $4.86 in Q1 2025 from $4.24 in Q1 2024.
• Adjusted Net Income: Increased to $83,074K in Q1 2025 compared to $79,831K in Q1 2024.
• Dividends: Cash dividends per share increased from $0.40 in Q1 2024 to $0.50 in Q1 2025.
• Operating Cash Flow: Maintained liquidity with available credit under revolving credit facilities amounting to approximately $404.5 million.

Negative Aspects:

• Cost of Services: Increased to $430,530K from $385,127K year-over-year, which could pressure margins.
• Decline in Other Income: Other income decreased significantly to $1,245K in Q1 2025 from $12,577K in Q1 2024.
• Adjusted EBITDA Margin: Decreased to 18.8% in Q1 2025 from 19.5% in Q1 2024, reflecting cost pressures.
• Accounts Receivable: Increased substantially by $114.7 million due to the reclassification of the OAS deposit, reflecting potential cash flow issues.

Key Statistics:

• Service Revenues and Sales: $646,943K (Q1 2025) vs. $589,233K (Q1 2024)
• Cost of Services: $430,530K (Q1 2025) vs. $385,127K (Q1 2024)
• Net Income: $71,757K (Q1 2025) vs. $65,017K (Q1 2024)
• Earnings Per Share: $4.86 (Q1 2025) vs. $4.24 (Q1 2024)
• Dividends Per Share: $0.50 (Q1 2025) vs. $0.40 (Q1 2024)
• Adjusted EBITDA: $121,692K in Q1 2025

In summary, Chemed Corporation shows strong top-line growth and improved net income. However, the increasing costs and shifts in accounts receivable management could raise concerns moving forward. Investors should keep an eye on how these factors impact the overall financial health of the company in upcoming quarters.